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Abstract 
Introduction: Ageing brings an increased 
burden on healthcare systems. In Malta 
cardiovascular disease is the main cause of 
morbidity and mortality accounting for 
approximately 40% of all deaths.  It is assumed that 
effective prevention strategies targeted at the 
middle-aged population would translate in better 
health outcomes in our elderly population. 
Aim: To investigate how lack of awareness of 
conditions such as high blood pressure and high 
blood glucose level in the 41-60-year age group 
could influence the health status of future 
generations of elderly in our population.  
Methodology: Two risk factors for 
cardiovascular disease namely raised blood pressure 
and raised blood glucose were identified for 
analysis: (i)  The comparison of perception and 
measurement of the selected risk factors assessed in 
2 cohorts aged 41-60 years at two different time 
points: (a) 1981/4 and (b) 2008/2010; (ii) The 
analysis of any changes in perception and 
measurement of these risk factors over time 
between the 1981/4 sample and a follow-up sample 
drawn from the first cohort 30 years later, now 60 
plus years of age. 
 
Results: Awareness for hypertension has 
increased in the 41-60-year olds over the 30-year 
period. However, awareness for diabetes has 
decreased in the same cohorts. Awareness for both 
hypertension and diabetes has increased as the 41-
60-year olds reach 60+.  
Conclusion: Improved perception for 
hypertension and diabetes in the 60+ group is not 
matched with better control of the condition. 
Medical intervention in the 41-60-age group in the 
2008/2010 sample has resulted in better control of 
blood pressure, but not of blood glucose. These 
results highlight the need for stepping up awareness 
and screening for these conditions especially in the 
41-60 group coupled with better control.  
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Introduction 
Demographic changes are affecting Europe and 
Malta is no exception. Locally individuals aged 65 
years and over are projected to increase from 
15.16% in 2010 to 31.7% by 2060. In fact, the 
population of persons aged 65 years and over is 
projected to reach 111,700 – an increase of 72% 
when compared to this segment of the population in 
2010.1 An ageing population presents challenges for 
our societies, economies and healthcare systems. 
The importance of healthy and active ageing cannot 
be over emphasized.  
In this study the focus shall be on hypertension 
and diabetes, two contributory risk factors for 
diseases of the circulatory system which accounted 
for 46.7% of all deaths in Malta in 2012.2  Of these 
diseases, ischaemic heart disease was responsible 
for 27.5% of deaths from all causes and was the 
most important cause of premature mortality, in 
those less than 65 years of age.2 Although these 
figures may indicate the size of the problem, they 
do not reflect the impact of the actual burden of 
disease in middle age and beyond, both on the 
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individual and on the healthcare services. This 
necessitates the need to embark on increasing 
awareness, effective prevention strategies, 
opportunistic screening and lifestyle changes 
particularly targeted to delay the onset of diseases 
of the circulatory system.  
A literature review was conducted of similar 
studies to be able to compare our findings. 
Awareness and actual presence of these conditions 
will be analysed in comparative local studies of 2 
cohorts aged 41-60 years at two different time 
points (1981/84 and 2008/2010). A subgroup of the 
surveyed population, 41-60 year 1981/84 cohort 
was followed as it reached 60 plus age group.  
Evaluation of the public health strategies issued 
from time to time and their influence on health 
behaviour and outcomes on the population will be 
explored. Also, the paper will focus on areas of 
possible failure of health promotion in halting the 
rising prevalence of hypertension and diabetes 
through increased awareness and the introduction of 
healthy lifestyles from a young age thus reducing 
the associated morbidity and mortality from 
circulatory diseases.  
 
Method 
The study set out to measure the awareness 
index which is the proportion of percentage of 
individuals with perceived disease and the actual 
percentage of individuals with the condition. 
(Awareness Index = % perceived disease / % 
measured disease or ratio expressed as a proportion 
of perceived to measured disease). An awareness 
index of zero (0) is equivalent to no awareness, 
whereas an awareness index of one (1) denotes full 
awareness.  
Data on self-reported perception and actual 
measurement of raised blood pressure and raised 
blood glucose was available from studies performed 
in Malta. These include the Diabetes survey 
performed in 1981, the Multinational MONitoring 
of Trends and Determinants in Cardiovascular 
Disease (MONICA Project) in 1984, the European 
Health Information Survey (EHIS)3 in 2008 and the 
European Health Examination Survey (EHES) done 
in 2010.4  
Each of these surveys was a separate cross 
sectional study based on a representative sample of 
the population. No attempt has been made to 
actively resample any of the previous studies’ 
population.  
A problem in health surveys that use only 
questionnaires is that the individual’s perception of 
having a disease may be different to whether that 
person is actually suffering from the condition or 
not. In medical surveys, there is a tendency of 
underreporting of the condition which may lead to 
serious bias in estimates of disease prevalence. This 
limitation is usually overcome by combining a 
questionnaire with a health examination. This has 
been the case in the Diabetes and MONICA surveys 
and the EHES whilst the European Health 
Information Survey (EHIS) only consisted of a 
questionnaire (Fig. 1).  
A person was considered to be hypertensive 
or diabetic if a raised blood pressure or raised blood 
glucose (fasting or random) was found upon 
examination or if the individual was known to be 
hypertensive or diabetic but was found to have a 
normal blood pressure or a normal blood glucose on 
examination.  Normal blood pressure was assumed 
to be when systolic blood pressure was <140mmHg 
and diastolic blood pressure was <90mmHg. 
Normal blood glucose level was taken to be 
≤7.1mmol/l after fasting for 8 hours and 
≤11.1mm0l/l for a random sample of blood glucose.  
In the Diabetes survey, a representative 
sample of 1,100 households was contacted out of 
which 1,098 agreed to participate. All members of 
the household 15 years and older participated; 
giving a total sample of 2,945 individuals. 
Individuals interviewed were asked a variety of 
questions including whether they had been ever 
diagnosed as diabetic. The purpose of this question 
was to avoid giving a glucose tolerance test to 
known diabetics because of the deleterious effect 
such a high dose of glucose can have on them. 
Unfortunately, the survey does not identify non-
diabetics who said that they had been diagnosed 
with diabetes as the latter were not given a glucose 
challenge as this could have had a deleterious effect 
on the perceived condition.5  
The MONICA survey assessed risk factors for 
heart disease through a questionnaire with linkage 
to results of the physical examination for 2,067 
individuals.  
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Figure 1: Timeline of studies; type of data obtained and age groups of cohorts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A random sample of 5,124 individuals was 
selected to participate in the EHIS, out of which 
3,680 participated given a response rate of 72%. 
Awareness for hypertension or diabetes was 
assessed according to self-reported data on the 
hypertensive and diabetic status of the participants 
in response to the question: ‘Have you had the 
disease/ condition-(hypertension/diabetes) in the 
past 12 months?’3  
In order to obtain more robust information 
about the health of the population, DG SANCO has 
embarked on a European Health Examination 
Survey (EHES) in 2014-2015; a pilot examination 
survey collecting information on both diabetes and 
hypertension was performed in 2010.  Although, 
this pilot study had a small sample size of 221 
individuals which may limit its validity, the sample 
was representative of the population. Information 
obtained from the EHIS and EHES (pilot study) has 
been amalgamated to give a more robust picture of 
the perception and actual presence of diabetes and 
hypertension in the population.  
 
Results 
Results (Table 1) show that the awareness 
index for hypertension 41-60 age-group has 
increased over the thirty-year period; today’s 41-60-
year olds are more aware of their condition than 
they were 30 years ago. Awareness for hypertension 
increases with age in that the original cohort of 41-
60 year olds became more aware of hypertension as 
they grew older. However, no difference has been 
found in awareness in today’s 41-60 year olds when 
compared to those who are 60+ years of age.  
Results showed that whilst the prevalence of 
high blood glucose has remained the same, there 
was a dramatic decrease in awareness index from 
0.73 to 0.57 in 41-60-year olds over a period of 30 
years. However, as the 1981 41-60-year cohort 
reach 60+, awareness for raised blood glucose 
approached maximum level from 0.73 to 0.96, 
which is a positive finding.  
Results show that the awareness index for 
both conditions has increased over a thirty- year 
period as the 41-60-year old reached 60+. In fact, 
55% of those having a raised blood pressure were 
aware of the condition and 96% of those found to 
have elevated blood glucose were cognisant of the 
condition. This finding contrasts to what was found 
in the two 41-60 year-age cohorts i.e. the 1984 and 
2008/2010 cohorts, when although awareness for 
hypertension increased that for diabetes decreased.  
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Table 1: Awareness Index for Blood Pressure and Blood Glucose 
Age Group Study & date Cohort 
No. 
Blood Pressure (BP) Blood Glucose (BG) 
Perceived  Measured  Awareness 
Index 
 
Perceived 
(%) 
Measured 
(%) 
Awareness 
Index 
4
1
-6
0
 y
rs
 
Diabetes1 
1981 
BG n=949 
 
27(%) 67(%) 0.40 9(%) 12(%) 0.73 
MONICA2 
1984 
  BPn=917 
EHIS3 
2008 
BGn=1278 
BPn=1283 
25(%) 46(%) 0.55 7(%) 12(%) 0.57 
EHES3 
2010 
BG n=125 
BP n=115 
6
0
+
 y
rs
 
EHIS3 
2008 
BG n=923 
BP n=921 
47(%) 86(%) 0.55 21(%) 22(%) 0.96 
EHES3 
2010 
BG n=76 
BP n=83 
1 Diabetes Survey: Perception and measurement of of blood glucose 
2 MONICA SURVEY: Perception and measurement of blood pressure 
3EHIS: Perception of blood glucose and blood pressure 
4EHES: Measurement of blood glucose and blood pressure using a weighted sample; weights were applied 
against EHIS because of small study. Inforamtion obtained from EHIS and EHES has been amalgamanated to 
give a more robust pictureof the perception and actual presence of diabetes and hypertension2 
 
Discussion 
When interpreting the results one must be 
cognisant of the fact that the cohorts studied, in 
particular the 41-60-year old cohort, are 
heterogeneous with the consequence that the age of 
onset or age of diagnosis of hypertension or 
diabetes differs. This heterogeneity is likely to 
impact on both prognosis and awareness.  
Awareness for a condition may lead an individual to 
undergo a medical check-up which could in turn 
lead to early diagnosis of the condition. On the 
other hand being diagnosed with a condition does 
not necessarily result in good control of the 
condition. Improvement in awareness for 
hypertension from 40% to 55% was noted among 
Maltese persons aged 41-60-years in 1981/84 upon 
reaching age 60+ years in 2008/2010. This is 
supported by findings from the Eurobarometer 
2007,6 NHANES7 and from the Canadian Health 
Measures survey.8 However, current awareness 
levels at 55% are less than satisfactory given the 
wider availability of health promotion and 
educational material and the relative ease of access 
to care. One has to question whether the message is 
reaching our population and having the desired 
effect. The European Health Literacy Survey 
revealed that nearly half of the Europeans have 
inadequate or problematic ability to understand, 
assimilate and act on health messages received. 
This is associated with riskier behaviour, poorer 
health, less self-management and higher 
hospitalization and health costs.9 
Comparing the two 41-60 year-age group 
cohorts i.e. the 1981/4 and 2008/2010, shows that 
over a 30-year period, there was improved 
awareness for hypertension but decreased 
awareness for diabetes. Less awareness for diabetes 
is very surprising since diabetes is usually 
symptomatic and tends to be diagnosed early. This 
finding may be attributed to the small numbers 
studied. Although the study showed that there 
seems to be no increase in prevalence in diabetes in 
the two 41-60-age cohorts (1981/4 and 2008/10), 
there is a possibility that the number of diabetics 
was inflated in the Diabetes survey due to the fact 
that the survey did not identify non-diabetics who 
said that they had been diagnosed with diabetes. 
Deep lack of awareness in the 41-60-age group 
cannot but be the harbinger of more diabetic 
complications once this cohort reaches old age and 
is cause for concern as diabetes tends to contribute 
heavily towards morbidity, hospital stays and 
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mortality in Malta and calls for deeper exploration.  
As the population gets older, awareness 
improves considerably with awareness for elevated 
blood glucose in the 60+ years age group being 
noticeably higher (96%) than for high blood 
pressure (55%). This may be due to the fact that 
elevated blood glucose is more symptomatic and 
individuals tend to seek medical advice earlier on. 
Increased awareness may be attributed to several 
factors including; (i) more visits to the family 
doctor, (ii) increased registration of patients with a 
specific family doctor, (iii) increased access of 
family doctors through E Health portal to previous 
blood glucose results and thus closer monitoring of 
the patient, (iv) improved access to health 
promotion campaigns through the conventional 
channels but also through the social media, (v) 
increased availability of home monitoring devices 
among family and friends that encourage people to 
check for hypertension or diabetes and (vi) 
increased availability of these tests in community 
pharmacies. More awareness enhances the checking 
of blood pressure and blood glucose with possible 
earlier diagnosis of the condition.  
Whilst the above trends in awareness and 
measuements have not been reported previously, 
this discussion would be incomplete if certain 
changes in underlying contributory factors, already 
reported elsewhere in the literature, are not 
considered. These include a significant increase in 
the percentage of persons with a normal BMI within 
the 41-60 age-group and an increase in percentage 
of persons having a desirable serum cholesterol 
level in both age groups in 2010 (Table 2). 
 
Table 2: BMI and cholesterol measures in the populations under study 
Age Group BMI% Total Cholesterol % 
 
Normal Overweight Obese Desirable Borderline High 
41-60 (1981) 
 n=930 
20.9 42 37.1 n.a.** n.a.** n.a.** 
41-60 (1984) 
BMI n=838 
CHOL n=566 
23.4 39.4 37.2 14.1 25.1 60.8 
41-60 (2010) 
BMI n=104* 
CHOL n=120* 
35.6 28.8 35.6 26.7 46.7 26.7 
60+ (2010) 
BMI n=87* 
CHOL n=77* 
24.1 41.4 34.5 27.3 41.6 31.2 
*weighted count, weights applied to the sample against EHIS because of very small study 
**Cholesterol measurements were not taken in the diabetes study 
 
When the persons aged 41-60 years in 
1981/1984 reached the 60+ years in 2010, the 
improvement in their BMI is negligible but the 
percentage of individuals with a desirable serum 
cholesterol level has doubled. This may be due to 
multiple confounding variables; increased 
receptiveness to health promotion messages 
stressing the need to monitor serum cholesterol, the 
availability of better and free cholesterol lowering 
drugs on the Schedule V Government Formulary 
and the interest of the pharmaceutical industry.  
However, the same cannot be said for messages 
advocating a change in lifestyle, as the BMI 
remained grossly unchanged. This implies selective 
uptake of health promotion messages. Furthermore, 
lifestyle modifications are more difficult to instil in 
later life. The Diabetes Prevention Programme 
(DPP) demonstrated that lifestyle interventions 
involving a healthy, low calorie, low-fat diet and 
moderate physical activity, in individuals at risk of 
developing diabetes are cost-saving in individuals 
younger than 45 years of age and cost-effective in 
all age groups when compared to Metformin and 
placebo interventions. The lifestyle intervention 
was highly cost effective, costing $1,100 per QALY 
when compared to the Metformin intervention 
costing approximately $31,300 per QALY.10 Cost-
saving interventions present no difficulty with 
respect to policy implications and should be 
introduced earlier on in life especially in individuals 
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at high risk of developing diabetes.  Cost-saving 
should also be factored in when devising guidelines. 
Guidelines should be effective in reducing 
morbidity and mortality but would provide added 
value if they are cost-effective. Evaluation of the 
2014 guidelines for US adults was made using the 
Cardiovascular Disease Policy Model to simulate; 
(i) drug-treatment and monitoring of costs, (ii) costs 
averted for the treatment of cardiovascular disease 
and (iii) quality-adjusted life years (QALYs) gained 
by treating previously untreated adults between the 
ages of 35 and 74 years from 2014 through 2024. 
The implementation of these guidelines could 
potentially prevent about 56,000 cardiovascular 
events and 13,000 deaths annually. Treatment of 
stage 1 hypertension was found to be cost-effective 
for all men and for women between the ages of 45 
and 74 years (defined as <$50,000 per QALY) 
amongst other benefits.11 Thus besides providing 
the optimal treatment for a condition, guidelines 
provide added value if they are cost-effective.  
Strategies help us achieve our goals but they 
need to have realistic, measurable targets that are 
attainable within stipulated time frames. For 
instance, there is no available evidence that the key 
targets outlined in the Health Vision 2000 published 
in 1995 for blood pressure and blood glucose have 
been achieved. These stated that by 2005, the 
diastolic blood pressure distribution in the general 
population should be reduced by 10mmHg and that 
by 2000, the prevalence of non-insulin dependent 
diabetes mellitus among those aged 34 and older is 
to be reduced to 7.5% or less and Impaired Glucose 
Tolerance should be reduced to 9% or less. 
Although these targets may not have been achieved, 
a downward trend in the age-standardized mortality 
rate from diseases of the circulatory system is 
observed. Recent strategies have formulated three 
(3) targets for the reduction of risk factors for 
circulatory diseases include: (i) reducing the 
prevalence of self-reported hypertension in Maltese 
adults by 3%, (ii) limiting the prevalence of 
diabetes among persons aged 34 years and over to 
10%,12 (iii) curbing and reversing the trend of 
overweight and obesity in children and adults, thus 
diminishing the consequences of excess body 
weight on health, social and economic aspects.13 
Hopefully these strategies will have the desired 
outcomes.  
This study has certain limitations as although 
the results are representative of the population it 
was not possible to divide the population by gender 
as the EHES numbers were too small. The low 
power may limit the conclusions drawn from the 
observed potential decline in awareness index for 
diabetes in the 41-60 year olds from 1981/4 to 
2010. The following assumptions were made that (i) 
the sample taken of the 60 plus age group 
(2008/2010) was representative of the original 
samples of the 41-60 age groups of the 1981/84 
groups and (ii) there were no significant changes in 
the health profiles of these two groups. 
 
Conclusion 
Life expectancy in Malta has increased and this 
presents the health service providers with new 
challenges. A sustainable healthcare system must be 
responsive to the changing needs of the population. 
The results illustrate that the formulation of 
strategies as standalone initiatives do not lead to the 
desired health outcomes. Notwithstanding their 
inherent validity, they need to be supported by new 
work practices and work processes. Also, one must 
keep in mind the importance of lifelong health 
promotion and education targeting all the 
population young and old, so that healthy habits are 
instilled early, thus delaying onset of disease. 
In order for public health messages and 
initiatives to reach and be understood by the 
population, the cultural belief, patients’ perspectives 
and health literacy levels need to be considered. 
Identifying gaps in awareness can help physicians 
and policymakers improve disease management and 
education programmes.  
The introduction of cost-saving or cost 
effective interventions in individuals at high risk to 
develop diabetes or hypertension presents no 
difficulty with respect to policy implications and 
should be introduced earlier on in life.    
 The role of all health professionals and in 
particular family doctors cannot be overemphasized 
as the latter are usually the first point of contact of 
the patients. Family doctors are encouraged to 
perform opportunistic screening for hypertension 
and diabetes and to keep abreast with guidelines on 
weight management and developments in the 
treatment of hypertension and diabetes so that they 
can manage these conditions optimally.  
Improved awareness for risk factors of 
circulatory disease, in particular for hypertension 
and diabetes, would empower persons to seek 
advice earlier from better informed health 
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professionals. In fact, the strategy entitled “A 
National Health Systems Strategy for Malta 2014-
2020”14 proposes leaps in health attainment by 
improving and increasing preventive, screening and 
health promotion services to ‘healthy’ citizens and 
by promoting and streamlining interactions between 
different services to ensure continuity of care. 
Improving access to healthcare and better synergy 
between primary and secondary care would 
translate in better health outcomes for the 
population at large.   
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